Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy.
Masjedi A, Ahmadi A, Ghani S, Malakotikhah F, Nabi Afjadi M, Irandoust M, Karoon Kiani F, Heydarzadeh Asl S, Atyabi F, Hassannia H, Hojjat-Farsangi M, Namdar A, Ghalamfarsa G, Jadidi-Niaragh F.
Masjedi A, et al. Among authors: ghani s.
Nanomedicine. 2020 Oct;29:102240. doi: 10.1016/j.nano.2020.102240. Epub 2020 Jun 15.
Nanomedicine. 2020.
PMID: 32553948